ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 365 filers reported holding ASTRAZENECA PLC in Q2 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,576,345 | -4.2% | 230,011 | +1.3% | 0.04% | -2.3% |
Q2 2023 | $16,258,486 | +12.1% | 227,169 | +8.8% | 0.04% | +19.4% |
Q1 2023 | $14,498,708 | +304239.0% | 208,885 | +197.3% | 0.04% | +176.9% |
Q4 2022 | $4,764 | -99.9% | 70,264 | -2.4% | 0.01% | +8.3% |
Q3 2022 | $3,946,000 | -14.3% | 71,967 | +3.3% | 0.01% | -7.7% |
Q2 2022 | $4,606,000 | -3.3% | 69,701 | -3.0% | 0.01% | +8.3% |
Q1 2022 | $4,765,000 | +15.0% | 71,820 | +1.0% | 0.01% | +20.0% |
Q4 2021 | $4,142,000 | -4.7% | 71,101 | -1.8% | 0.01% | -9.1% |
Q3 2021 | $4,348,000 | +9.4% | 72,392 | +9.2% | 0.01% | +10.0% |
Q2 2021 | $3,973,000 | +18.7% | 66,317 | -1.5% | 0.01% | +11.1% |
Q1 2021 | $3,347,000 | -42.1% | 67,325 | -41.8% | 0.01% | -47.1% |
Q4 2020 | $5,781,000 | -41.5% | 115,647 | -35.9% | 0.02% | -50.0% |
Q3 2020 | $9,880,000 | +28.4% | 180,295 | +24.0% | 0.03% | +17.2% |
Q2 2020 | $7,693,000 | +87.1% | 145,457 | +58.0% | 0.03% | +52.6% |
Q1 2020 | $4,112,000 | -49.7% | 92,055 | -43.8% | 0.02% | -34.5% |
Q4 2019 | $8,172,000 | +16.0% | 163,884 | +3.7% | 0.03% | +3.6% |
Q3 2019 | $7,045,000 | +9.1% | 158,049 | +1.0% | 0.03% | +12.0% |
Q2 2019 | $6,460,000 | +207.2% | 156,483 | +200.8% | 0.02% | +108.3% |
Q1 2019 | $2,103,000 | +5.2% | 52,028 | -1.2% | 0.01% | -14.3% |
Q4 2018 | $2,000,000 | -3.2% | 52,658 | +0.7% | 0.01% | +7.7% |
Q3 2018 | $2,066,000 | +3.3% | 52,305 | -8.2% | 0.01% | -7.1% |
Q2 2018 | $2,000,000 | +12.4% | 56,959 | +12.0% | 0.01% | +7.7% |
Q1 2018 | $1,779,000 | -3.5% | 50,867 | -4.3% | 0.01% | 0.0% |
Q4 2017 | $1,843,000 | +1.7% | 53,126 | -0.7% | 0.01% | -7.1% |
Q3 2017 | $1,813,000 | -3.1% | 53,521 | -2.5% | 0.01% | -6.7% |
Q2 2017 | $1,871,000 | +13.0% | 54,894 | +3.2% | 0.02% | +15.4% |
Q1 2017 | $1,656,000 | +15.1% | 53,190 | +1.0% | 0.01% | +8.3% |
Q4 2016 | $1,439,000 | -15.4% | 52,656 | +1.8% | 0.01% | -20.0% |
Q3 2016 | $1,700,000 | +6.9% | 51,737 | -1.8% | 0.02% | 0.0% |
Q2 2016 | $1,591,000 | +5.9% | 52,684 | -1.2% | 0.02% | +7.1% |
Q1 2016 | $1,502,000 | -27.3% | 53,340 | -12.4% | 0.01% | -33.3% |
Q4 2015 | $2,067,000 | +7.0% | 60,888 | +0.3% | 0.02% | 0.0% |
Q3 2015 | $1,931,000 | +5.8% | 60,688 | +111.8% | 0.02% | +16.7% |
Q2 2015 | $1,825,000 | – | 28,650 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |